Abstract:
PURPOSE: A compound isolated from a Hemistepita lyrata Bunge extract, and a composition containing the same for preventing and treating dandruff are provided to strongly suppress M. obtuse, and to be used as an external use skin pharmaceutical composition or a cosmetic composition for preventing and treating dandruff. CONSTITUTION: A pharmaceutical composition for preventing and treating dandruff contains hemistepsin A, hemistepsin B, or a pharmaceutically acceptable salt thereof isolated from a Hemistepita lyrata Bunge extract as an active ingredient. The pharmaceutical composition is a cream, a gel, a patch, a spray, an ointment, a lotion, a liniment, a paste, or a cataplasma formulation. A cosmetic composition for preventing and treating dandruff contains hemistepsin A, hemistepsin B, or a pharmaceutically acceptable salt thereof as an active ingredient.
Abstract:
PURPOSE: An external use composition containing a complex crude drug extract containing cypress phytoncide is provided to suppress dandruff without side effects or toxicity. CONSTITUTION: A pharmaceutical composition for external use for preventing alopecia, suppressing dandruff, and promoting hair growth contains a complex crude drug extract containing ginger, mulberry, Rehmannia glutinosa var. purpurea, Angalica gigas Nakai, and cypress phytoncide as an active ingredient. The extract is prepared using water including purified water, C1-C4 alcohol, or a mixture thereof. [Reference numerals] (AA) Control group; (BB) 8-th group;